Gamma delta (γδ) T cells are a mysterious and often-ignored component of the immune system. Like B cells and alpha beta (αβ) T cells, they are characterized by the expression of a germline rearranged antigen receptor, which uniquely makes use of TCR δ and TCR γ gene segments. Our current understanding of γδ T cells points to a versatile population that does not follow the rules established for the better-studied αβ T cells. γδ T cells have received recent attention as tissue-resident sentinels, but also represent a potent effector population in the blood. The γδ TCR repertoire can be hugely diverse, largely oligoclonal, or essentially invariant, depending on location and ligand specificity. The γδ T cell lineage is ancient, conserved from jawed fish to humans, but functionally divergent between mouse and humans, making findings from each difficult to harmonize. It is tempting to apply principles of αβ T cell biology to their less studied γδ counterparts. However, these assumptions can lead us to overlook the special character of γδ T cells and misunderstand their contribution to human immunity. Likewise, drawing parallels between mouse γδ T cells and human γδ T cells can obfuscate the many outstanding questions that remain about γδ T cell ontogeny and function in humans. In this review, we will attempt to separate assumption from fact by dissecting features of human γδ T cells that have been shown empirically and comparing them, where relevant, to their counterparts in the mouse model. The two main subsets of γδ T cells in humans are classified by their δ chain usage, Vδ1 or Vδ2, which appear to define their divergent modes of ligand recognition and function. Vδ1 T cells are relatively rare in the blood but are significantly represented in barrier tissues and expand dramatically in response to viral infections.